EI
APLT

Ethic Inc’s Applied Therapeutics APLT Stock Holding History

Ethic Inc’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27,193
Closed -$16.4K – 1213
2025
Q3 		$16.4K Sell
27,193
-1,436
-5% -$676 ﹤0.01% 1189
2025
Q2 		$9.27K Buy
28,629
+10,662
+59% +$4.13K ﹤0.01% 1210
2025
Q1 		$8.27K Buy
+17,967
New +$10.6K ﹤0.01% 1161

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Ethic Inc's APLT Position: Q4 2025 in Review

Ethic Inc sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 27,193 shares — an estimated $16.4K sold.

Ethic Inc first reported a position in APLT in Q1 2025 and held it in 3 quarters. The position peaked at $16.4K in Q3 2025. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

  • Ethic Inc reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Ethic Inc sold 27,193 Applied Therapeutics shares in Q4 2025, an estimated $16.4K.
  • Ethic Inc first reported a position in Applied Therapeutics in Q1 2025 and held it in 3 quarters.
  • Ethic Inc's Applied Therapeutics position peaked at $16.4K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Ethic Inc's 13F filing for Q4 2025, filed 3 Feb 2026.